MedTrace Logo

A Clinical Trial Investigating the Efficacy and Safety of a Lipase Thera-blend and a Lipase Thera-blend + Tributyrin on Memory in Healthy Adults With Self-reported Memory Problems

NCT07020494 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-03-31

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate the efficacy and safety of Lipase Thera-blend and Lipase Thera-blend + tributyrin on memory in healthy adults with self-reported memory problems. The main question\[s\] it aims to answer \[is/are\]:

Does of Lipase Thera-blend improve memory in healthy adults? Does Lipase Thera-blend + tributyrin improve memory in healthy adults?

Researchers will compare Lipase Thera-blend and Lipase Thera-blend + tributyrin against a placebo to see if the investigational products improve memory parameters.

Participants will be asked to consume either placebo, Lipase Thera-blend, or Lipase Thera-blend + tributyrin and asked to complete memory questionnaires to assess memory.

Conditions

  • Self-reported Memory Problems
  • Memory

Interventions

DIETARY_SUPPLEMENT

Lipase Thera-blend

Participants will be instructed to consume take one capsule three times a day with food for the duration of the study period.

DIETARY_SUPPLEMENT

Lipase Thera-blend + tributyrin

Participants will be instructed to consume take one capsule three times a day with food for the duration of the study period.

OTHER

Placebo

Participants will be instructed to consume take one capsule three times a day with food for the duration of the study period.

Sponsors & Collaborators

  • KGK Science Inc.

    collaborator INDUSTRY

  • Enzymedica

    lead INDUSTRY

Principal Investigators

  • David Crowley, MD · KGK Science Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-25
Primary Completion
2026-02-13
Completion
2026-02-13

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07020494 on ClinicalTrials.gov